BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 44 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $21,883,000 | -48.1% | 20,680,000 | -46.8% | 0.01% | -26.7% |
Q4 2019 | $42,177,000 | +25.4% | 38,875,000 | +19.0% | 0.02% | +15.4% |
Q3 2019 | $33,639,000 | -18.0% | 32,664,000 | -10.8% | 0.01% | -18.8% |
Q2 2019 | $41,046,000 | +11.0% | 36,608,000 | +12.3% | 0.02% | 0.0% |
Q1 2019 | $36,969,000 | +5.5% | 32,608,000 | +3.5% | 0.02% | -5.9% |
Q4 2018 | $35,031,000 | -12.4% | 31,500,000 | -5.6% | 0.02% | 0.0% |
Q3 2018 | $39,995,000 | +12.2% | 33,381,000 | +8.9% | 0.02% | +6.2% |
Q2 2018 | $35,631,000 | +9.3% | 30,656,000 | +3.9% | 0.02% | +6.7% |
Q1 2018 | $32,598,000 | +1629800.0% | 29,501,000 | +1474950.0% | 0.02% | – |
Q4 2017 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | -100.0% | 2,000 | -100.0% | 0.00% | -100.0% |
Q2 2017 | $21,944,000 | -6.0% | 18,425,000 | -6.8% | 0.01% | -15.4% |
Q1 2017 | $23,337,000 | +11.8% | 19,767,000 | +12.4% | 0.01% | +18.2% |
Q4 2016 | $20,878,000 | +2.6% | 17,592,000 | +7.8% | 0.01% | 0.0% |
Q3 2016 | $20,351,000 | +12.2% | 16,322,000 | +4.0% | 0.01% | 0.0% |
Q2 2016 | $18,144,000 | -24.7% | 15,692,000 | -22.9% | 0.01% | -26.7% |
Q1 2016 | $24,089,000 | -11.9% | 20,348,000 | +0.2% | 0.02% | -16.7% |
Q4 2015 | $27,337,000 | -2.5% | 20,298,000 | -2.2% | 0.02% | -14.3% |
Q3 2015 | $28,036,000 | -14.0% | 20,758,000 | +0.5% | 0.02% | -8.7% |
Q2 2015 | $32,618,000 | +15.3% | 20,658,000 | +10.8% | 0.02% | +15.0% |
Q1 2015 | $28,297,000 | +81.3% | 18,638,000 | +46.3% | 0.02% | +100.0% |
Q4 2014 | $15,612,000 | +9.6% | 12,738,000 | -2.1% | 0.01% | 0.0% |
Q3 2014 | $14,249,000 | -14.9% | 13,013,000 | -18.1% | 0.01% | -9.1% |
Q2 2014 | $16,737,000 | +7.2% | 15,893,000 | +13.0% | 0.01% | 0.0% |
Q1 2014 | $15,615,000 | +76.6% | 14,068,000 | +70.1% | 0.01% | +83.3% |
Q4 2013 | $8,842,000 | – | 8,268,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,340,750,000,000 | 1.66% |
OAKTREE CAPITAL MANAGEMENT LP | 66,800,000 | $70,446,000 | 1.23% |
Man Investments (CH) AG | 2,600,000 | $2,743,000 | 1.11% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,425,000 | 0.81% |
ADVENT CAPITAL MANAGEMENT /DE/ | 35,763,000 | $38,870,000 | 0.58% |
Jabre Capital Partners S.A. | 5,900,000 | $6,240,000 | 0.44% |
SSI INVESTMENT MANAGEMENT LLC | 3,039,000 | $3,198,000 | 0.31% |
AVIVA PLC | 37,700,000 | $39,724,000 | 0.30% |
BNP PARIBAS FINANCIAL MARKETS | 3,000,000 | $315,929,984,000 | 0.30% |
Calamos Advisors LLC | 44,222,000 | $46,596,000 | 0.30% |